Ironwood Pharmaceuticals, Inc.

    Jurisdiction
    United States
    LEI
    549300PC8MR6QHH6P296
    ISIN
    US46333X1081 (IRWD)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. Read full profile

    Fundamentals

    Net revenue
    €263.15M
    Gross margin
    99.7%
    EBIT
    €64.09M
    EBIT margin
    24.4%
    Net income
    -€5.93M
    Net margin
    -2.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €219.72M -16.5% €35.55M -699.5%
    €152.68M -30.5% -€12.79M -136.0%
    €133.91M -12.3% -€16.21M +26.7%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Gaskins Tammi L Chief Commercial Officer -1.3K $0.84 -$1.11K
    John Minardo Chief Legal Officer -7.8K $0.84 -$6.51K
    Martini Gregory S. Chief Financial Officer -1.3K $0.84 -$1.06K
    Silver Ronald Principal Accounting Officer -2.8K $0.84 -$2.39K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 9.9M $14.61M +874K Buy

    Earnings Calls

    Latest earnings call: May 9, 2024 (Q1 2024)

    Add to watchlist

    Notifications